Pluristem Therapeutics Inc., of Haifa, Israel, appointed Jeffrey Olin, Manesh Patel, Petra Reinke and J. Andre Schmidt-lucke to its new peripheral artery disease steering committee...PTC Therapeutics Inc., of South Plainfield, N.J., named Claudia Hirawat president and Mark Boulding executive vice president and chief legal officer

Constellation Pharmaceuticals Inc., of Cambridge, Mass., named Keith Dionne president and CEO and Mark Goldsmith executive chairman of the board...Intermune Inc., of Brisbane, Calif., added Jean-Jacques Bienaime and Frank Verwiel to its board...OvaScience, of Cambridge, Mass., added Jeffrey Capello and John Simon to its board

3SBio Inc., of Shenyang, China, named Jing Lou board chairman and added Dongmei Su to its board...Anaphore Inc., of La Jolla, Calif., added Peppi Prasit and Raymond Stevens to its board...Silence Therapeutics plc, of London, appointed Detlef Schuppan and Massimo Pinzani to its newly created scientific advisory board

CombiMatrix Corp., of Irvine, Calif., appointed Richard Ding and Joseph Limber to its board...and Christine Mikail, executive vice president, corporate development, general counsel and secretary

Sirona also appointed Sean Cunliffe chief business officer and board member...Trovagene Inc., of San Diego, named Charlie Rodi vice president and chief technology officer...ValiRx plc, of London, named Hilary Calvert, Richard Harbottle and Jean-Frederic Sauniere to its scientific advisory board

ImmunoGen Inc., of Waltham, Mass., added Kristine Peterson and Dean Mitchell to its board...and added Eunan Maguire senior vice president of strategy and corporate development

ImmunoGen Inc., of Waltham, Mass., added Kristine Peterson and Dean Mitchell to its board...and added Eunan Maguire senior vice president of strategy and corporate development

Acella Pharmaceuticals Inc., of Atlanta, appointed Allen Fields vice president and head of R&D...Rusty" Williams president and CEO and named Brian Atwood chairman

Acella Pharmaceuticals Inc., of Atlanta, appointed Allen Fields vice president and head of R&D...Adeona Pharmaceuticals Inc., of Ann Arbor, Mich., appointed Jeff Riley president and CEO, added C. Evan Ballantyne as chief financial officer and named Scott L. Tarriff and Nelson K. Stacks to the board...AMAG Pharmaceuticals Inc., of Lexington, Mass., appointed Rajiv De Silva and Gino Santini to its board

The revisions will reflect technological advancements and marketing developments that have emerged over the past decade...Viewed as a way to take the hard choices of curbing Medicare expenses out of the hands of Congress, the board – made up of presidential appointments confirmed by the Senate – is charged with cutting Medicare costs if its spending exceeds a predetermined target growth rate. (See BioWorld Today, July 14, 2011, and Sept. 20, 2011.) Although President Barack Obama has proposed

It also added John E. Dick and Janet Rossant to its scientific and clinical advisory board...Zealand Pharma A/S, of Copenhagen, Denmark, named Alain Munoz and Christian Grøndahl joint chairs to its new clinical and scientific advisory board

Pharmalink AB, of Stockholm, Sweden, elected Anders Wiklung chairman and added Elisabeth Lindner to the board...Promosome LLC, of New York, added Edward R. Robinson and Loren A. Busby to its board...It also appointed Louis Brenner chief medical officer and elected Kurt Graves chairman

NeoStem Inc., of New York, appointed Martyn D. Greenacre and Andrew L. Pecora to the board...NexImmune Inc., of Gaithersburg, Md., appointed Kenneth Carter CEO and named Jonathan Schneck chairman of the clinical and scientific advisory board

NeoStem Inc., of New York, appointed Martyn D. Greenacre and Andrew L. Pecora to the board...NexImmune Inc., of Gaithersburg, Md., appointed Kenneth Carter CEO and named Jonathan Schneck chairman of the clinical and scientific advisory board

InteRNA Technologies BV, of Utrecht, the Netherlands, appointed Mark Vaeck and Sanne Weijzen to its board chaired by Anker Lundemose...It also named Robert B. Shapiro and Jeffrey B. Kindler to its board

Codexis Inc., of Redwood City, Calif., named Wesley J. Bolsen vice president and chief marketing officer...Curis Inc., of Lexington, Mass., appointed Maurizio Voi chief medical and chief development officer

Accera Inc., of Broomfield, Colo., appointed Holger Kunze CEO and board member...BioTime Inc., of Alameda, Calif., and its subsidiary, OncoCyte Corp., each appointed Andrew von Eschenbach to their boards...CBio Ltd., of Brisbane, Australia, named Ralph Craven chairman and appointed Helen Cameron interim managing director

Hilary Malone as vice president and chief regulatory and compliance officer...and Jim Rouse as vice president and chief information officer

Lycera Corp., of Ann Arbor, Mich., named Kathleen M. Metters president and CEO...Medivir AB, of Huddinge, Sweden, appointed Maris Hartmanis president and CEO...PDL BioPharma Inc., of Incline Village, Nev., retained Franklin M. Berger and Evan Bedil as advisors to assist with the identification and evaluation of royalty-bearing asset acquisition opportunities